<DOC>
	<DOCNO>NCT00681798</DOCNO>
	<brief_summary>The purpose study define th Maximum Tolerated Dose ( MTD ) recommend dose ( RD ) ZD6474 combination fix standard dose gemcitabine capecitabine</brief_summary>
	<brief_title>Dose Escalation Study With Zactima Chemotherapy Metastatic Pancreas Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Confirmed diagnosis locally advance unresectable metastatic pancreatic adenocarcinoma ECOG performance status &lt; 1 Measurable disease Severe uncontrolled systemic disease Clinically significant cardiac event myocardial infarction Any concomitant medication may cause OTc prolongation , include Torsades de Pointes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>pancreatic cancer</keyword>
	<keyword>pancreatic adenocarcinoma</keyword>
	<keyword>pancreas cancer</keyword>
	<keyword>dose escalation study</keyword>
	<keyword>locally advanced unresectable pancreatic adenocarcinoma</keyword>
	<keyword>Zactima</keyword>
	<keyword>Vandetanib</keyword>
	<keyword>ZD6474</keyword>
</DOC>